GlassScriptPhysician profile
James Chandler
NPI 1043297310
$2,615.79
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $210 · 2023: $452 · 2024: $1,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,469 · Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,468.77 |
| Food and Beverage | $936.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $977.70 | 2024 | |
| Peerless Surgical INC. | $763.37 | 2022-2024 | |
| Stryker Corporation | $480.84 | 2022-2024 | Prostep, Citrefix, Prophecy |
| Tactile Systems Technology INC | $92.35 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Paragon 28, INC. | $76.95 | 2023 | Portfolio |
| Bioventus LLC | $45.88 | 2023-2024 | Durolane, Durolane |
| Integra Lifesciences Corporation | $40.38 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.75 | 2023 | Zilretta, Iovera, Exparel |
| Linvatec Corporation | $31.28 | 2023 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Hall Power |
| Orthofix Medical, INC. | $28.20 | 2023 | Physio-Stim |
| Depuy Synthes Sales INC. | $23.90 | 2023 | Na |
| Kerecis Limited | $19.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.